central
nervou
system
cn
demyelin
diseas
multipl
sclerosi
ms
myelin
damag
impair
impuls
conduct
along
denud
axon
limit
remyelin
occur
ms
lesion
typic
insuffici
prevent
longterm
neurolog
disabl
demyelin
event
improv
remyelin
could
maxim
function
recoveri
viabl
axon
prevent
associ
axon
damag
degener
rodent
model
extens
spontan
remyelin
function
recoveri
possibl
episod
acut
transient
demyelin
prolifer
immatur
cell
differenti
myelin
oligodendrocyt
requir
extens
remyelin
similarli
immatur
oligodendrocyt
lineag
cell
persist
adult
human
cn
may
prolifer
increas
number
within
near
ms
lesion
howev
immatur
cell
often
fail
differenti
suffici
remyelin
throughout
extent
ms
lesion
therefor
repair
capac
endogen
cell
may
limit
nonpermiss
signal
chronic
ms
lesion
growth
factor
cytokin
cell
adhes
molecul
may
regul
oligodendrocyt
progenitor
op
differenti
remyelin
oligodendrocyt
environ
demyelin
lesion
among
potenti
signal
molecul
examin
vivo
role
endogen
fibroblast
growth
factor
upregul
postnat
develop
acut
demyelin
remyelin
acut
demyelin
null
mice
exhibit
enhanc
oligodendrocyt
repopul
demyelin
lesion
improv
oligodendrocyt
regener
studi
use
vivo
retrovir
lineag
analysi
wildtyp
versu
null
mice
demonstr
predomin
effect
vivo
remyelin
inhibit
op
differenti
current
studi
examin
whether
effect
op
differenti
oligodendrocyt
regener
signific
impact
remyelin
acut
demyelin
model
rodent
typic
exhibit
spontan
remyelin
may
robust
prevent
appropri
evalu
strategi
improv
remyelin
therefor
current
studi
challeng
capac
endogen
cell
regener
oligodendrocyt
remyelin
chronic
demyelin
lesion
induc
activ
demyelin
mice
ad
cuprizon
diet
return
normal
chow
would
allow
analysi
spontan
remyelin
without
ongo
diseas
pathogenesi
cuprizon
reproduc
demyelin
corpu
callosum
mice
spontan
remyelin
greatli
reduc
chronic
cuprizon
demyelin
contrast
acut
demyelin
importantli
chronic
cuprizon
demyelin
axon
remain
viabl
remyelin
transplant
op
cell
chronic
demyelin
model
current
studi
demonstr
dramat
improv
remyelin
endogen
cell
mice
genet
delet
compar
wildtyp
mice
thu
express
chronic
lesion
may
limit
remyelin
attenu
may
gener
suffici
permiss
environ
spontan
remyelin
endogen
cell
mice
bred
maintain
uniform
servic
univers
health
scienc
usuh
anim
hous
facil
procedur
perform
accord
guidelin
nation
institut
health
societi
neurosci
usuh
institut
anim
care
use
committe
knockout
mice
svev
black
swiss
genet
background
obtain
breed
heterozyg
pair
provid
dr
doetschman
univers
cincinnati
knockout
gener
target
delet
replac
portion
gene
includ
bp
promot
entir
first
exon
hprt
minigen
cuprizon
ingest
result
reproduc
pattern
extens
corpu
callosum
demyelin
cuprizon
treatment
start
week
age
male
mice
use
cuprizon
ww
fine
powder
oxal
bi
cyclohexylidenehydrazid
sigmaaldrich
st
loui
mo
thoroughli
mix
chow
diet
harlan
teklad
madison
wi
avail
ad
libitum
mice
maintain
cuprizon
diet
perfus
analysi
return
normal
chow
week
week
cuprizon
ingest
mice
perfus
paraformaldehyd
brain
dissect
overnight
postfix
paraformaldehyd
brain
tissu
cryoprotect
overnight
sucros
frozen
oct
compound
immunostain
situ
hybrid
situ
hybrid
prepar
digoxigeninlabel
riboprob
perform
previous
detail
antisens
riboprob
use
detect
mrna
transcript
proteolipid
protein
plp
gift
dr
lynn
hudson
nation
institut
health
gift
dr
bill
richardson
univers
colleg
london
digoxigeninlabel
riboprob
hybrid
coron
brain
section
digoxigenin
detect
alkalin
phosphataseconjug
sheep
antidigoxigenin
antibodi
boehring
mannheim
indianapoli
follow
reaction
nbtbcip
substrat
dako
carpinteria
ca
identifi
op
situ
coron
brain
section
immunostain
primari
antibodi
use
rabbit
polyclon
antibodi
gift
dr
william
stallcup
la
jolla
ca
rat
monoclon
antibodi
pharmingen
san
diego
ca
donkey
antirabbit
igg
f
ab
conjug
jackson
immunoresearch
west
grove
pa
use
detect
wherea
detect
biotinyl
donkey
antirat
igg
f
ab
jackson
immunoresearch
follow
coumarin
tyramid
amplif
new
england
nuclear
boston
myelin
immunostain
monoclon
antibodi
recogn
myelin
oligodendrocyt
glycoprotein
mog
hybridoma
cell
provid
dr
minetta
gardini
univers
iowa
mog
immunolabel
detect
donkey
antimous
igg
f
ab
conjug
jackson
immunoresearch
cell
prolifer
estim
immunostain
antigen
express
nuclei
activ
divid
cell
absent
recogn
rat
monoclon
antibodi
mous
antigen
dako
follow
detect
abc
elit
kit
use
dab
substrat
vector
lab
burlingam
ca
imag
situ
hybrid
immunostain
result
captur
spot
ccd
digit
camera
use
spot
advanc
imag
acquisit
softwar
diagnost
instrument
sterl
height
mi
olympu
microscop
imag
prepar
panel
use
adob
photoshop
san
jose
ca
compar
cell
densiti
quantif
perform
investig
blind
treatment
condit
cell
express
plp
mrna
quantifi
use
unbias
stereolog
morphometr
analysi
stereolog
system
system
plan
analysi
inc
alexandria
va
analysi
restrict
corpu
callosum
region
midlin
extend
later
cingulum
coron
section
use
stereolog
system
specimen
thick
contribut
sampl
volum
measur
reflect
unbias
stereolog
method
could
use
appropri
condit
rel
cell
interest
chosen
categori
therefor
quantif
cell
corpu
callosum
express
requir
count
label
cell
use
spot
ccd
camera
softwar
measur
area
sampl
result
densiti
unit
quantif
corpu
callosum
myelin
estim
mog
immunofluoresc
detect
spot
ccd
camera
use
metamorph
softwar
pixel
intens
valu
normal
section
threshold
exclud
valu
level
immunoreact
dorsal
fornix
select
adjac
white
matter
tract
demyelin
cuprizon
percent
area
corpu
callosum
midlin
bilater
point
cingulum
apex
mog
immunoreact
threshold
level
use
estim
myelin
area
categori
analyz
includ
three
tissu
section
per
mous
three
mice
per
condit
except
larger
sampl
size
note
text
andor
figur
legend
oneway
analysi
varianc
anova
post
hoc
tukey
multipl
comparison
test
use
determin
signific
differ
among
stage
diseas
progress
treatment
unpair
student
ttest
use
compar
genotyp
nonles
mice
signific
genotyp
effect
across
multipl
treatment
condit
calcul
use
twoway
anova
statist
comparison
made
mice
differ
genet
background
ie
mice
mice
mice
use
establish
paramet
analyz
later
manipul
capac
endogen
oligodendrocyt
lineag
cell
repopul
remyelin
chronic
demyelin
lesion
use
cuprizon
model
take
advantag
abil
stop
activ
demyelin
simpli
return
mice
normal
diet
character
mice
continu
cuprizon
ingest
result
persist
demyelin
variabl
degre
partial
remyelin
indic
regen
potenti
endogen
cell
even
mice
still
fed
cuprizon
howev
week
continu
cuprizon
ingest
mice
spontan
remyelin
remain
limit
recoveri
period
fig
poor
remyelin
chronic
demyelin
contrast
almost
complet
remyelin
seen
recoveri
period
acut
demyelin
ie
week
cuprizon
follow
week
cuprizon
fig
better
evalu
underli
caus
limit
remyelin
chronic
demyelin
character
oligodendrocyt
lineag
cell
respons
rel
diseas
progress
focu
repair
potenti
oligodendrocyt
op
popul
character
multipl
stage
diseas
progress
nonles
cuprizon
acut
demyelin
week
continu
cuprizon
chronic
demyelin
week
continu
cuprizon
recoveri
chronic
demyelin
week
continu
cuprizon
follow
normal
chow
week
situ
hybrid
use
identifi
oligodendrocyt
express
plp
mrna
transcript
fig
op
cell
express
plateletderiv
growth
factor
receptor
mrna
transcript
fig
quantit
analysi
oligodendrocyt
popul
reveal
ongo
partial
regener
chronic
demyelin
fig
oligodendrocyt
densiti
lowest
initi
week
cuprizon
acut
phase
week
continu
cuprizon
oligodendrocyt
densiti
continu
sever
reduc
rel
valu
nontreat
mice
ongo
partial
regener
chronic
demyelin
indic
fact
oligodendrocyt
densiti
week
higher
initi
week
end
chronic
cuprizon
treatment
oligodendrocyt
regener
improv
recoveri
period
interestingli
shown
figur
remyelin
progress
similarli
recoveri
period
plp
mrna
situ
hybrid
use
identifi
oligodendrocyt
detect
premyelin
myelin
oligodendrocyt
plp
transcript
preced
myelin
format
result
indic
chronic
demyelin
proport
premyelin
oligodendrocyt
gener
recoveri
period
may
fail
differenti
myelin
oligodendrocyt
op
popul
dynam
dramat
differ
respons
acut
versu
chronic
demyelin
fig
respons
initi
episod
acut
demyelin
op
popul
amplifi
almost
fourfold
fig
howev
end
chronic
demyelin
period
op
densiti
greatli
reduc
remain
low
recoveri
period
chronic
lesion
similar
result
observ
op
identif
use
fig
use
week
cuprizon
n
week
cuprizon
plu
week
recoveri
n
week
cuprizon
plu
week
recoveri
n
week
cuprizon
treatment
cell
corpu
callosum
identifi
activ
undergo
mitosi
use
dapi
counterstain
reveal
mitot
chromatin
figur
activ
divid
cell
also
immunostain
inset
fig
immunostain
nuclear
antigen
use
broadli
identifi
activ
cycl
cell
within
corpu
callosum
fig
cycl
cell
present
less
half
densiti
op
cell
cycl
popul
although
still
rel
small
significantli
increas
within
corpu
callosum
mice
fed
cuprizon
week
compar
agematch
control
mice
recov
week
chronic
demyelin
togeth
find
demonstr
compromis
continu
op
cycl
regener
oligodendrocyt
chronic
demyelin
subsequ
recoveri
period
fig
express
increas
acut
cuprizon
demyelin
inhibit
op
differenti
oligodendrocyt
regener
subsequ
remyelin
use
situ
hybrid
mrna
transcript
shown
elev
express
persist
within
chronic
cuprizon
lesion
compar
nonles
corpu
callosum
fig
mrna
transcript
abund
relat
chang
protein
detect
develop
white
matter
acut
demyelin
predict
chronic
lesion
inhibit
differenti
could
contribut
limit
capac
gener
remyelin
oligodendrocyt
fig
especi
context
reduc
op
pool
fig
although
endogen
popul
effici
remyelin
chronic
cuprizon
demyelin
mice
fig
transplant
op
cell
shown
axon
remain
viabl
remyelin
therefor
use
chronic
demyelin
model
knockout
mice
test
whether
repair
endogen
op
popul
might
improv
remov
endogen
lesion
environ
extent
demyelin
week
cuprizon
ingest
similar
mice
mice
wildtyp
null
genotyp
fig
percentag
corpu
callosum
area
myelin
immunolabel
mice
mice
chronic
demyelin
mice
myelin
immunostain
corpu
callosum
significantli
increas
recoveri
period
fig
surprisingli
myelin
immunostain
recov
approxim
nonles
level
week
remov
cuprizon
diet
mice
contrast
mice
fig
mice
fig
myelin
proport
corpu
callosum
area
significantli
increas
recoveri
period
strike
improv
remyelin
correspond
dramat
increas
oligodendrocyt
repopul
chronic
lesion
mice
found
mice
fig
cuprizon
treatment
nonles
mice
similar
densiti
oligodendrocyt
corpu
callosum
week
age
correspond
longest
cuprizon
treatment
recoveri
protocol
addit
cuprizoneinduc
loss
oligodendrocyt
mice
similar
end
chronic
cuprizon
treatment
conjunct
quantit
myelin
immunostain
analysi
find
indic
mice
experienc
similar
chronic
diseas
sever
importantli
recoveri
period
chronic
demyelin
oligodendrocyt
densiti
return
nonles
valu
mice
mice
analysi
addit
intermedi
recoveri
period
mice
confirm
increas
oligodendrocyt
regener
demonstr
repopul
could
occur
within
week
remov
cuprizon
diet
previous
show
absenc
significantli
alter
op
amplif
respons
acut
cuprizon
demyelin
robust
op
prolif
respons
occur
week
cuprizon
null
wildtyp
mice
similar
previous
mention
data
mice
fig
howev
op
popul
deplet
chronic
demyelin
contrast
amplifi
op
respons
acut
demyelin
fig
therefor
examin
effect
genotyp
densiti
op
cell
cycl
cell
corpu
callosum
chronic
demyelin
genotyp
appear
alter
op
popul
dynam
chronic
demyelin
mice
agematch
nonles
mice
fig
densiti
op
cell
identifi
situ
hybrid
mrna
similar
mice
mice
fig
somewhat
unexpectedli
mice
null
wildtyp
genotyp
svev
black
swiss
genet
background
exhibit
increas
op
cell
densiti
week
cuprizon
observ
mice
fig
strain
differ
op
accumul
chronic
demyelin
correspond
fewer
oligodendrocyt
observ
recoveri
period
mice
fig
compar
mice
fig
therefor
background
appear
even
less
favor
background
op
differenti
oligodendrocyt
regener
yet
detriment
effect
chronic
lesion
environ
still
overcom
mice
immunostain
fig
indic
densiti
cycl
cell
corpu
callosum
less
densiti
op
cell
indic
rel
low
level
ongo
prolifer
cell
nuclear
immunoreact
often
observ
doublet
appropri
confirm
detect
cycl
popul
densiti
cell
immunolabel
nuclear
antigen
increas
chronic
lesion
corpu
callosum
return
nonles
level
recoveri
phase
densiti
endogen
cell
prolifer
corpu
callosum
mice
similar
valu
mice
fig
b
mice
fig
similar
mice
mice
analysi
op
cell
cycl
cell
indic
dramat
differ
observ
oligodendrocyt
remyelin
may
result
permiss
effect
remov
op
differenti
remyelin
oligodendrocyt
ms
lesion
initi
episod
transient
demyelin
may
follow
spontan
remyelin
howev
remyelin
typic
fail
recur
chronic
myelin
damag
current
studi
show
advantag
cuprizon
model
chronic
demyelin
focus
compromis
repair
respons
importantli
analysi
mice
demonstr
possibl
overcom
chronic
lesion
effect
endogen
oligodendrocyt
lineag
cell
increas
remyelin
specif
taken
togeth
previou
work
find
mice
indic
remov
inhibit
op
differenti
promot
spontan
remyelin
deplet
pool
endogen
progenitor
persist
chronic
demyelin
current
find
mice
consist
previou
report
cuprizon
treatment
caus
extens
demyelin
corpu
callosum
mous
strain
take
advantag
model
examin
mechan
promot
remyelin
endogen
cell
character
endogen
oligodendrocyt
lineag
popul
respons
recoveri
period
use
mice
part
studi
facilit
comparison
studi
differ
mous
strain
influenc
respons
cuprizon
well
overal
cellular
respons
cn
injuri
transient
episod
demyelin
week
cuprizon
ingest
spontan
remyelin
effect
throughout
corpu
callosum
contrast
prolong
period
demyelin
week
continu
cuprizon
remyelin
remain
limit
progress
recoveri
interv
examin
week
limit
remyelin
correspond
deplet
op
pool
current
studi
howev
number
oligodendrocyt
increas
somewhat
recoveri
period
without
correspond
increas
remyelin
corpu
callosum
taken
togeth
find
indic
deplet
op
pool
limit
capac
gener
oligodendrocyt
avail
op
cell
may
fail
fulli
differenti
remyelin
oligodendrocyt
environ
chronic
lesion
lesion
ms
case
immatur
oligodendrocyt
progenitor
premyelin
oligodendrocyt
may
present
rel
normal
densiti
without
effici
remyelin
therefor
studi
import
better
understand
regul
op
pool
size
transit
op
cell
premyelin
myelin
oligodendrocyt
robust
op
prolifer
respons
acut
demyelin
appear
requir
spontan
remyelin
acut
demyelin
op
pool
dramat
amplifi
effici
differenti
matur
oligodendrocyt
may
requir
extens
remyelin
pdgfaa
ligand
act
activ
import
mitogen
op
amplif
respons
acut
cuprizon
demyelin
heterozyg
mice
amplif
op
pool
respons
acut
cuprizon
demyelin
compromis
correspond
gener
oligodendrocyt
reduc
cross
heterozyg
mice
mice
actual
increas
oligodendrogli
repopul
lesion
acut
cuprizon
demyelin
therefor
acut
chronic
lesion
environ
remov
may
promot
gener
oligodendrocyt
op
cell
remyelin
endogen
predict
contribut
prolifer
neonat
adult
op
especi
present
combin
pdgfaa
base
vitro
studi
current
analysi
densiti
op
cell
cell
similar
wildtyp
null
genotyp
result
consist
previou
brdu
incorpor
studi
indic
endogen
predomin
mitogen
op
acut
cuprizon
model
howev
subtl
chang
prolifer
rate
among
asymmetr
divid
op
pool
could
rel
difficult
detect
small
popul
cell
prolong
diseas
recoveri
cours
also
predict
stimul
neural
stem
cell
subventricular
zone
svz
contribut
repopul
corpu
callosum
lesion
prolong
demyelin
period
current
studi
contribut
cell
deriv
svz
evid
dynam
op
pool
corpu
callosum
lack
detriment
effect
absenc
op
pool
may
indic
effect
svz
cell
may
signific
contribut
remyelin
overli
corpu
callosum
howev
direct
analysi
respons
cell
svz
requir
make
determin
addit
endogen
elev
lesion
may
elicit
specif
effect
replic
vivo
method
elev
exogen
level
among
effect
neuroprotect
growth
factor
divers
model
cn
injuri
includ
stroke
trauma
excitotox
axotomi
contrast
expect
protect
effect
neuron
remov
endogen
actual
improv
regen
paramet
lesion
involv
remyelin
improv
regener
oligodendrocyt
observ
mice
acut
cuprizon
demyelin
corpu
callosum
murin
hepat
viru
strain
demyelin
spinal
cord
current
studi
exampl
peripher
nervou
system
knockout
mice
use
prevent
normal
upregul
fgf
receptor
fgfr
activ
associ
schwann
cell
macrophag
site
sciatic
nerv
crush
injuri
compar
wildtyp
mice
knockout
mice
exhibit
improv
myelin
increas
axon
diamet
regener
sciatic
nerv
crush
result
indic
detriment
effect
endogen
remyelin
may
outweigh
protect
acut
axon
damag
lesion
model
inde
improv
remyelin
nerv
knockout
mice
may
provid
signific
protect
axon
damag
subsequ
initi
crush
injuri
correl
support
similar
role
chronic
autoimmun
model
ms
found
studi
neural
stem
cell
transplant
improv
mice
experiment
allerg
encephalomyel
eae
transplant
mice
exhibit
improv
remyelin
major
contribut
endogen
cell
less
axon
loss
lesion
area
neural
stem
cell
transplant
also
associ
signific
decreas
express
reduc
astrogli
scar
format
eae
lesion
level
may
modul
scar
format
demyelin
lesion
express
correspond
scar
nonscar
astrogli
respons
form
cn
injuri
yet
clear
fgfr
type
type
mediat
effect
endogen
context
demyelin
remyelin
differenti
effect
differ
stage
oligodendrocyt
lineag
may
occur
differenti
express
activ
fgfr
isoform
oligodendrocyt
lineag
cell
express
highaffin
fgfr
coreceptor
vari
development
stage
exposur
furthermor
express
multipl
fgfr
type
significantli
increas
respons
demyelin
may
also
differenti
effect
base
chang
interact
signal
pathway
regul
oligodendrocyt
lineag
differenti
myelin
neuregulin
interpret
direct
effect
complic
neuron
glial
cell
express
multipl
fgfr
type
within
near
demyelin
lesion
therefor
futur
studi
requir
identifi
specif
signal
compon
mediat
endogen
signal
vivo
context
demyelin
remyelin
ms
lesion
patholog
heterogen
effect
oligodendrocyt
lineag
popul
vari
dramat
oligodendrocyt
densiti
sever
compromis
demyelin
lesion
patient
ms
studi
imper
optim
regen
respons
immatur
oligodendrocyt
lineag
cell
popul
observ
ms
lesion
target
inhibitori
signal
upregul
lesion
viabl
strategi
therapeut
promot
differenti
need
near
lesion
express
report
reactiv
astrocyt
acut
chronic
ms
plaqu
addit
cultur
adult
human
brain
white
matter
inhibit
differenti
preoligodendrocyt
oligodendrocyt
strategi
promot
remyelin
attenu
inhibit
op
differenti
may
take
advantag
reagent
modul
signal
current
develop
angiogenesi
cancer
treatment
vivo
analysi
absenc
detriment
normal
adult
throughout
diseas
process
therefor
inhibit
signal
may
accept
across
demyelin
diseas
stage
would
improv
treatment
feasibl
diseas
ms
unstabl
diseas
cours
treatment
promot
remyelin
valuabl
complement
strategi
abrog
ongo
caus
demyelin
immunomodulatori
therapi
